Annual Total Liabilities
$873.49 M
+$660.16 M+309.46%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual total liabilities is currently $873.49 million, with the most recent change of +$660.16 million (+309.46%) on 31 December 2023. During the last 3 years, it has risen by +$690.98 million (+378.59%). AMPH annual total liabilities is now at all-time high.AMPH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$817.50 M
+$39.32 M+5.05%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly total liabilities is currently $817.50 million, with the most recent change of +$39.32 million (+5.05%) on 30 September 2024. Over the past year, it has dropped by -$131.99 million (-13.90%). AMPH quarterly total liabilities is now -13.90% below its all-time high of $949.49 million, reached on 30 September 2023.AMPH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +309.5% | -13.9% |
| 3 y3 years | +378.6% | +269.1% |
| 5 y5 years | +485.4% | +437.9% |
AMPH Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +378.6% | -13.9% | +283.2% |
| 5 y | 5 years | at high | +485.4% | -13.9% | +447.0% |
| alltime | all time | at high | +939.4% | -13.9% | +837.5% |
Amphastar Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $817.50 M(+5.1%) |
| June 2024 | - | $778.18 M(-13.7%) |
| Mar 2024 | - | $901.96 M(+3.3%) |
| Dec 2023 | $873.49 M(+309.5%) | $873.49 M(-8.0%) |
| Sept 2023 | - | $949.49 M(+20.3%) |
| June 2023 | - | $789.03 M(+250.6%) |
| Mar 2023 | - | $225.08 M(+5.5%) |
| Dec 2022 | $213.33 M(-5.6%) | $213.33 M(-3.7%) |
| Sept 2022 | - | $221.53 M(-1.3%) |
| June 2022 | - | $224.41 M(-5.2%) |
| Mar 2022 | - | $236.71 M(+4.7%) |
| Dec 2021 | $226.01 M(+23.8%) | $226.01 M(+2.0%) |
| Sept 2021 | - | $221.50 M(+11.6%) |
| June 2021 | - | $198.52 M(+1.9%) |
| Mar 2021 | - | $194.78 M(+6.7%) |
| Dec 2020 | $182.51 M(+14.5%) | $182.51 M(+12.1%) |
| Sept 2020 | - | $162.76 M(+3.3%) |
| June 2020 | - | $157.62 M(+5.5%) |
| Mar 2020 | - | $149.46 M(-6.3%) |
| Dec 2019 | $159.44 M | $159.44 M(+4.9%) |
| Sept 2019 | - | $151.98 M(-10.1%) |
| June 2019 | - | $169.01 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $164.45 M(+10.2%) |
| Dec 2018 | $149.20 M(+27.2%) | $149.20 M(+7.1%) |
| Sept 2018 | - | $139.37 M(+6.3%) |
| June 2018 | - | $131.12 M(+6.9%) |
| Mar 2018 | - | $122.68 M(+4.6%) |
| Dec 2017 | $117.34 M(+19.1%) | $117.34 M(+9.5%) |
| Sept 2017 | - | $107.11 M(-3.2%) |
| June 2017 | - | $110.68 M(+0.6%) |
| Mar 2017 | - | $110.05 M(+11.7%) |
| Dec 2016 | $98.48 M(+4.1%) | $98.48 M(-1.9%) |
| Sept 2016 | - | $100.38 M(-0.7%) |
| June 2016 | - | $101.12 M(+2.7%) |
| Mar 2016 | - | $98.42 M(+4.0%) |
| Dec 2015 | $94.63 M(-12.0%) | $94.63 M(-14.9%) |
| Sept 2015 | - | $111.24 M(-2.1%) |
| June 2015 | - | $113.66 M(-3.0%) |
| Mar 2015 | - | $117.22 M(+9.0%) |
| Dec 2014 | $107.51 M(+23.3%) | $107.51 M(-8.9%) |
| Sept 2014 | - | $118.01 M(+7.7%) |
| June 2014 | - | $109.53 M(+17.1%) |
| Mar 2014 | - | $93.57 M(+7.3%) |
| Dec 2013 | $87.20 M(+3.8%) | $87.20 M |
| Dec 2012 | $84.04 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual total liabilities year-on-year change?
- What is Amphastar Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly total liabilities year-on-year change?
What is Amphastar Pharmaceuticals annual total liabilities?
The current annual total liabilities of AMPH is $873.49 M
What is the all time high annual total liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual total liabilities is $873.49 M
What is Amphastar Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, AMPH annual total liabilities has changed by +$660.16 M (+309.46%)
What is Amphastar Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of AMPH is $817.50 M
What is the all time high quarterly total liabilities for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly total liabilities is $949.49 M
What is Amphastar Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, AMPH quarterly total liabilities has changed by -$131.99 M (-13.90%)